Background: The Intergrowth-21st (IG) project proposed prescriptive fetal growth
| INTRODUC TI ON
Screening for suboptimal fetal growth is a key component of antenatal care. [1] [2] [3] Recently, the Intergrowth-21st (IG) project proposed international fetal growth standards based on serial ultrasound measurements collected in a cohort of healthy, well-nourished, pregnant women from geographically diverse populations in its Fetal Growth Longitudinal
Study. These standards are recommended for universal use in clinical care and research, based on the hypothesis that fetal growth is the same across populations when the health, nutritional, and health care needs of pregnant women are met. 4 Strict inclusion criteria, based on over twenty sociodemographic and clinical characteristics, were therefore imposed to identify the women included in the study.
5
The importance of differentiating between references (developed using the whole population) and standards (developed on a healthy sub-set of the population) was a central precept in the development of the World Health Organisation (WHO) postnatal growth standards, based on anthropometric measurements from multi-country samples of low-risk children. These standards are currently recommended for use worldwide, although their applicability to all populations has been called into question. [6] [7] [8] Proponents of these standards claim that they are intended to describe normal child growth and therefore are not expected to "fit" all populations.
9
The IG fetal growth norms also face criticism for not accurately reflecting fetal growth in a growing number of studies, either because too few 10 or too many fetuses 11 are classified under the 10th percentile or too few are classified as over the 90th percentile. 12 One reason for these discordant findings may be population selection.
Most of these studies did not use the IG criteria to select their study populations; however, there is some evidence from studies in low-risk populations that also reveal differences. 13, 14 For instance, the WHO recently released international standards for intrauterine growth generated using a low-risk international sample, and differences were observed when compared with IG. 14 While the WHO initiative, as well as the recent NICHD study to develop standards for the US population, 15 generated fetal growth standards using samples of low-risk pregnant women, they differ from IG in that they do not claim that their standards describe normative growth in all populations.
16
Given the debate about IG's universal applicability and its reliance on strict selection criteria for identifying prescriptive growth, we aimed to assess the applicability of the IG fetal growth standards to a French population of births overall and after selection applying the IG criteria. We used routinely measured biometric data from the ELFE French national birth cohort to apply the IG fetal growth standards and compared them with existing French references.
| MATERIAL AND ME THODS

| Study population: The Elfe birth cohort
The Elfe study is a French national birth cohort, which follows-up children from birth to adulthood in order to characterise the relationship between environmental exposures and the socioeconomic context and health and behaviours. Details concerning the rationale and design of the Elfe cohort were described previously and are also available on the study's website. 17 
| Data collection
The baseline assessment took place during the maternity hospital stay. Research assistants collected information during a face-to-face interview with the mothers, using a standardised self-administered questionnaire, and from the mother's medical records. Additional information was also collected by phone interview 2 months after delivery.
| Biometric records
Biometric measurements from the three routine ultrasounds were collected from medical records. For the purpose of this study, only measurements from the second and the third ultrasounds were ana- existence of a congenital anomaly in the newborn. Mothers were also asked whether conception followed subfertility treatment or occurred while using contraception.
| Socio demographic characteristics
| Population selection
The Elfe study included 18 329 births. After excluding 532 twins, 14 666 singleton births had biometric data and gestational age available for at least one of the 2nd or the 3rd trimester ultrasounds ( Figure S1 ). We excluded measurements performed before 16 weeks or after 38 weeks and extreme values, leaving a final study population of 14 607 births. The application of all the IG selection criteria for which information was available in the Elfe study resulted in a study population restricted to 4997 pregnancies.
| Comparison with French intrauterine references
We used the French College for Fetal Ultrasound references (henceforth called "French" references) as a comparison for the IG standards.
These references are recommended for use in the French population by the French College of Gynecologists and Obstetricians. French references were generated in an unselected population with few exclusion criteria and therefore differ in methodology from the IG growth standards. Table 1 summarises differences in the methods for the construction of both fetal growth charts.
| Statistical analyses
Data were first checked and cleaned in order to exclude erroneous biometric measures from analyses. In particular, biometrical measures with internal z-scores over 5 in absolute terms were deleted.
For this step, z-scores were calculated after modelling the mean and the standard deviation as a function of gestational age with the method of Altman and colleagues, 21 also employed by the IG project.
We described maternal and pregnancy characteristics of the entire study population and of the selected population based on the IG selection criteria. We also compared our study population to the women who were not included for analysis because they had missing biometric measurements. We then described the biometric data from the second and the third ultrasounds, and plotted the number of measurements for each gestational age from 16 to 38 weeks.
For each of the biometric measurements at the second and third trimester scans, we created z-scores based on the French references and the IG growth charts. Equations used for generating the z-scores are provided in Table S1 . We also computed the prevalence of fetuses with low and high biometric values based on the 3rd or the 10th percentile and on the 90th and the 97th percentiles, respectively, according to both growth charts, before and after applying the IG selection criteria. The mean and 95% confidence interval (CI) of the z-scores based on French references or on IG standards were represented graphically as a function of gestational age, smoothing the curve using a 3rd degree penalised B-spline. 22 We visually compared the z-scores curves based on the IG standards before and after applying the IG selection criteria.
| RE SULTS
| Description of the study sample
The 14 607 women in our sample were on average 30.6 years old at delivery; 87.1% of them were born in France, 59.7% had a bachelor degree or more, and 33.7% were primigravida ( Table 2 ). The 3190
women excluded from the analysis because of missing biometric data were older, more likely to be born in France, and had higher gestational age at birth on average; they were more likely to have higher education and to live with a partner, and less likely to have smoked or consumed alcohol during pregnancy. No differences were observed for gravidity, pregnancy complications, BMI, or preterm birth rates (Table S2) .
From the total sample, 4997 (34%) women remained after applying the IG exclusion criteria. Criteria leading to the most exclusions were older maternal age and smoking during pregnancy (present in about 20% of women), but other exclusion criteria such as alcohol consumption, pre-pregnancy obesity or underweight, financial hardship, conception following fertility treatment, and gestational diabetes were present in between 5% and 10% of women. As expected, the low-risk subsample was younger, more educated, and more often primigravida (Table 2) .
Median gestational age at the second and the third ultrasound was 22.3 and 32.4 weeks, respectively, with more than half of the data collected between 22 and 23 weeks and 32 and 33 weeks, respectively (Table 3 ). There were fewer data points available for abdominal circumference than for femur length. A more detailed description of the breakdown of data collected for femur length and abdominal circumference according to gestational week is displayed on Figure S2 . There were few data collected before 21 weeks, between 25 and 30 weeks, and after 34 weeks.
| Comparison of Elfe biometric data to the French references and the IG standards
The Elfe biometric data were on average very close to the French references, since mean z-scores for femur length and abdominal circumference at both ultrasounds varied from −0.2 to 0.1 (Table 4) The discrepancies observed with the IG standards are reflected in the prevalence of small and large for gestational age fetuses also displayed in Table 4 . Using IG standards, 2.5% and 5.2% of femur length and abdominal circumference values of the third ultrasound were under the 10th percentile, and 31.5% and 16.7% were over the 90th percentile for femur length and abdominal circumference, respectively. The corresponding proportions were 9.7%, 3.0%, 5.4%, and 7.1% using French references.
Results related to biparietal diameter are presented in (Table   S3 , Figures S2-S4 ). As expected, biparietal diameter z-score means based on IG standards were highly negative (−0.6 ± 1.1 at the 2nd and the 3rd ultrasound). More than 25% of biparietal diameter values were under the 10th IG percentile, and less than 5% of bipari- 
| Results after application of the IG inclusion criteria
The mean z-scores based on IG standards were very similar before and after selecting our population according to the very strict IG inclusion criteria ( Figure 2 ). Increased mean z-scores before 20 weeks should not be considered, since numbers were very low at these gestational ages (10 femur length measurements at 16 weeks, for example), and confidence intervals consequently very large. As shown in Table 4 , the prevalence of small and large for gestational age fetuses was also largely unchanged, with for example, only 2.1% and 4.6% of femur length and abdominal circumference values under the 10th IG percentile and 32.3% and 15.8% over the 90th IG percentile.
| Comment
| Principal findings
Biometric data from a large French birth cohort differed substantially from the IG fetal growth standards and were closer to current TA B L E 2 (Continued)
| Strengths of the study
The principal strengths of our study are the large sample of ultrasound measurements at two different moments during pregnancy and the availability of sociodemographic and clinical data obtained through medical chart review and interviews with mothers after delivery, making it possible to apply the IG selection criteria.
| Limitations of the data
Some women had missing ultrasound measurements (27%) primarily because ultrasound measures were not recorded in the obstetric files, as a very low proportion of women in France have fewer than the three recommended ultrasounds. 23 Indeed, ultrasound reports are not systematically included in hospitals' obstetrical records when ultrasounds are carried out by private providers.
However, we were able to describe the characteristics of women with missing data. They were more likely to have a higher education level, to smoke or consume alcohol during pregnancy than women included in our study, but did not differ in terms of the preterm birth rate or birthweight. We can assume that slight departure from representativeness would not affect the results obtained in the population selected after applying the stringent IG criteria.
Another potential limitation is that the ultrasound measure- 
| Interpretation
The mean z-score values of the biometric parameters from the Elfe study were close to the French references; however, some of the proportions of infants classified as SGA and LGA differed from the expected 3 or 10%, although to a lesser extent than when defined by the IG standards. Indeed, for most measurements, the IG standards were over half a standard deviation from the expected value of 0 for the z-scores, and they classified unexpectedly large numbers of fetuses as having high values. These findings were similar for both second and third trimester ultrasounds and for the unselected and low-risk samples. We were not able to investigate HC which was not IG, intergrowth; SD, standard deviation.
collected in the Elfe study, but a previous French study reported good concordance with IG standards based on a z-score and the 10th percentile, suggesting that this parameter performs differently from the femur length and abdominal circumference. 26 We also found large differences with the biparietal diameter, which were due to measurement methods and therefore not reported in our main results. However, this example illustrates the caution needed when using international standards at a national level where measurement protocols may differ.
There are no consensual criteria or thresholds for deciding whether the departure between standards and a population distribution is significant for research or clinical practice. Within the IG project, the decision to pool data across sites relied on the observation that the differences between each site and the overall mean at different gestational ages were under 0.5 SD. 27 This threshold is controversial, however, because there can still be large variations in proportions of fetuses with ultrasound parameters under the 10th percentile which has implications for the detection of growth restriction. 28 In our study, many of the differences in zscores were over the threshold set by the Intergrowth project.
The IG standard was developed to describe the distribution of fetal growth parameters in a target population, defined as healthy fetuses from low-risk pregnancies. Therefore, the only way to establish external validity is to test whether the standard accurately reflects the distribution of ultrasound parameters in other low-risk populations.
This study calls for caution in using the IG standards for clinical care in France. Growth references are used to identify fetuses 
Femur length Abdominal circumference
requiring more surveillance because of potentially suboptimal growth; many professional societies recommend that monitoring small for gestational age (SGA) fetuses [1] [2] [3] and identifying large for gestational age fetuses are important for the surveillance of women with gestational diabetes and for the management of delivery. [29] [30] [31] [32] Several studies have shown that failure to detect growth restriction among SGA fetuses is associated with higher rates of stillbirths and neonatal morbidity. [33] [34] [35] The IG standards would classify fewer fetuses as being SGA than the currently used references and could worsen performance, already judged to be sub-optimal, 29 for identifying SGA fetuses needing more surveillance. The IG standards would also classify more fetuses as LGA which could lead to unnecessary surveillance of these fetuses and possibly iatrogenic interventions, such as earlier delivery or caesarean.
32
Our finding that the differences in growth parameters between the sample restricted to women fulfilling the IG selection criteria and the overall population were very small is relevant for the current debate on growth standards vs. references. It shows that population selection is not an explanation for the differences between the IG standards and fetal growth in the ELFE cohort and is also unlikely to explain the differences found in other population-based studies. [10] [11] [12] [36] [37] [38] More broadly, this finding challenges the relevance of distinguishing between growth "references" and "standards" for fetal growth monitoring, at least in high-income settings where malnutrition is low and access to health services is high. A recent study within a Norwegian multi-ethnic population which applied IG criteria also showed that this did not reduce ethnic differences in fetal growth parameters. 13 In our study, the low-risk sample represented only one-third of the population, a finding corroborated by Sletner et al in Norway (21%). 13 Nonetheless, despite the very stringent restrictions used to identify low-risk pregnancies, the results were very similar, both with respect to mean values and pregnancies classified as SGA or LGA. In other words, our results suggest that growth patterns may not differ substantially between lower-risk vs. general population samples. Population selection is the primary justification for promoting growth curves as "population standards" as opposed to "population references" in both the IG and WHO-MGRS studies;
our results suggest this principle merits reconsideration and further testing.
| CON CLUS ION
We found large differences between IG standards and fetal biometric measures in the French Elfe birth cohort in both unselected and in healthy low-risk pregnancies, as defined by IG highly selective criteria. These results show that these international standards are not adapted to the French context and refute the IG hypothesis that fetal growth is similar across populations for low-risk healthy pregnancies. More generally, these results illustrate the need for more rigorous approaches to defining normative growth and validating prescriptive standards.
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